Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Danielle C. Kirkey"'
Autor:
Danielle C. Kirkey, Anisha M. Loeb, Sommer Castro, Cyd Nourigat McKay, LaKeisha Perkins, Laura Pardo, Amanda R. Leonti, Thao T. Tang, Michael R. Loken, Lisa Eidenschink Brodersen, Keith R. Loeb, David A. Scheinberg, Quy Le, Soheil Meshinchi
Publikováno v:
Blood Advances. 7:1178-1189
Preferentially Expressed Antigen in Melanoma (PRAME), a cancer-testis antigen, provides an ideal target for immunotherapy in acute myeloid leukemia (AML). We have shown expression of PRAME in a significant subset of childhood and adult AML and lack o
Autor:
Makia K. Manselle, Rhonda E. Ries, Tiffany Hylkema, Amanda Leonti, Danielle C. Kirkey, Scott N. Furlan, Soheil Meshinchi
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Makia K. Manselle, Rhonda E. Ries, Tiffany Hylkema, Amanda Leonti, Danielle C. Kirkey, Scott Furlan, Soheil Meshinchi
Acute Myeloid Leukemia (AML) patients have a wide array of cytogenetic and molecular aberrations which can influence response to therapy. Monosomy7 (Mono7) is a rare subset within pediatric AML (prevalence of 4-5%), that is highly associated with poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a538d9b0665be97c508330ed6d28771
https://doi.org/10.22541/au.166237204.49109217/v1
https://doi.org/10.22541/au.166237204.49109217/v1
Autor:
Danielle C. Kirkey, Xiaoying Wu, Rhonda E. Ries, Tiffany A. Hylkema, Yanling Liu, Pandurang Kolekar, Quang Tran, Alan S. Gamis, Richard Aplenc, Anders E. Kolb, Todd A. Alonzo, Katherine Tarlock, Robert Eisenman, Soheil Meshinchi
Publikováno v:
Blood. 140:3395-3396
Autor:
Minnie N. Dasgupta, Danielle C. Kirkey, Jake A. Weatherly, Kevin W. Kuo, Caroline E. Rassbach
Publikováno v:
Academic pediatrics. 22(3)
The ability to incorporate evidence-based medicine (EBM) into clinical practice is an Accreditation Council for Graduate Medical Education competency, yet many pediatric residents have limited knowledge in this area. The objective of this study is to
Autor:
Soheil Meshinchi, Richard Aplenc, Danielle C. Kirkey, Anders Kolb, Quang Tran, Xiaotu Ma, Yanling Liu, Amanda R. Leonti, Todd A. Alonzo, Jenny L. Smith, Quy Le, Rhonda E. Ries, Jessica A. Pollard, Leila Robinson, Katherine Tarlock, Yi-Cheng Wang
Publikováno v:
Blood. 138:609-609
KMT2A partial tandem duplication (KMT2A-PTD), characterized by a large internal duplication spanning 6-8 exons, has been documented in adult AML with a prevalence of 3-10% and is associated with poor outcomes. Despite the high prevalence of KTM2A fus